Furosemide CAS 54-31-9 Assay ≥99.0% Diuretic API Factory High Quality
I-Furosemide kunye neMidiya eNxulumeneyo:
Furosemide CAS 54-31-9
2,4-Dichloro-5-Sulfamoylbenzoic Acid CAS 2736-23-4
I-2,4-Dichlorobenzoic Acid CAS 50-84-0
| Igama leMchiza | Furosemide |
| Izithethantonye | I-5-(Aminosulfonyl) -4-chloro-2-[(2-furanylmethyl)amino]benzoic Acid;I-4-Chloro-N-furfuryl-5-sulfamoylanthranilic Acid |
| Inombolo yeCAS | 54-31-9 |
| Inombolo yeCAT | RF-API102 |
| Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
| Ifomula yeemolekyuli | I-C12H11ClN2O5S |
| Ubunzima beMolekyuli | 330.74 |
| Ukunyibilika | I-Soluble kwi-Acetone, i-DMF, i-Methanol;Ayinyibilikiyo emanzini |
| Uphawu | Ruifu Chemical |
| Into | Iinkcukacha |
| Imbonakalo | Umgubo weCrystalline oMhlophe okanye oMhlophe;Ayinavumba, Phantse ayinancasa |
| I-Furosemid | ≥99.0% |
| Indawo yokunyibilika | 206.0 ~ 210.0℃ |
| I-Coefficient yokufunxa | 565~595 |
| I-Chloride | ≤0.014% |
| Sulfate | ≤0.04% |
| Ilahleko ekomisweni | ≤0.50% |
| Intsalela kwi-Ignition | ≤0.10% |
| Iintsimbi ezinzima | ≤20ppm |
| Arsenic | ≤2ppm |
| Umgangatho woVavanyo | Umgangatho woShishino |
| Ukusetyenziswa | AbaPhakathi bamayeza |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.
I-Frusemide yi-loop diuretics esetyenziswa ngokubanzi kunyango lokungaphumeleli kwentliziyo kunye ne-edema.I-Frusemide, ethengiswa phantsi kwegama le-brand Lasix phakathi kwezinye, liyeza elisetyenziselwa ukunyanga ukwakheka kolwelo ngenxa yokusilela kwentliziyo, ukukrala kwesibindi, okanye isifo sezintso.Isenokusetyenziselwa unyango loxinzelelo lwegazi oluphezulu.IFurosemid isetyenziswa ikakhulu kunyango loxinzelelo lwegazi kunye ne-edema.Yeyona arhente yomgca wokuqala kubantu abaninzi abane-edema ebangelwa kukungaphumeleli kwentliziyo.Kwakhona isetyenziselwa i-hepaticcirrhosis, ukukhubazeka kwezintso, i-nephrotic syndrome, kwi-adjunct therapy ye-cerebral okanye i-pulmonary edema apho i-rapiddiuresis iyadingeka (i-IV injection), kunye nokulawulwa kwe-hypercalcemia enzima ngokudibanisa nokubuyisela okwaneleyo.
